Abstract
The structure-activity relationships of azetidine-based DPP IV inhibitors will be discussed in detail in the following review. The azetidine-based DPP IV inhibitors can be divided into three main subtypes, the 2-cyanoazetidines, 3-fluoroazetidines and 2-ketoazetidines. These subtypes have been explored and structure-activity relationships have been established by several groups. Several compounds within each of these subtypes display sub micromolar potency against DPP IV. The most potent cyanoazetidines and ketoazetidines have large, hydrophobic amino acid groups bound to the azetidine nitrogen and display activities below 100nM. DPP IV inhibition is not sensitive to stereochemistry at the 2- position as both 2-(R)- and 2-(S)-cyano and -keto azetidines display similar inhibitory potencies. While these “warhead”- based cyano- and ketoazetidines have the potential for covalent, bond-forming inhibition, they can also react to internally cyclize into inactive ketopiperazines and dihydroketopyrazine. Thus, chemical instability was also explored for compounds in these two subtypes and certain members of the cyanoazetidine series display aqueous stability comparable to the closely related cyanopyrrolidines. Select 3-fluoroazetidines also display inhibitory potencies below 1μM without the propensity for cyclization and chemical instability associated with the other subseries.
Keywords: Pyrrolidine Based DPP IV Inhibitors, ketone-based DPP IV inhibitors, Cyanopyrrolidine, fluoroazetidines, ketopyrrolidines
Current Topics in Medicinal Chemistry
Title: Azetidine-Based Inhibitors of Dipeptidyl Peptidase IV (DPP IV)
Volume: 7 Issue: 6
Author(s): Dana Ferraris, Sergei Belyakov, Weixing Li, Eddie Oliver, Yao-Sen Ko, David Calvin, Susan Lautar, Bert Thomas and Camilo Rojas
Affiliation:
Keywords: Pyrrolidine Based DPP IV Inhibitors, ketone-based DPP IV inhibitors, Cyanopyrrolidine, fluoroazetidines, ketopyrrolidines
Abstract: The structure-activity relationships of azetidine-based DPP IV inhibitors will be discussed in detail in the following review. The azetidine-based DPP IV inhibitors can be divided into three main subtypes, the 2-cyanoazetidines, 3-fluoroazetidines and 2-ketoazetidines. These subtypes have been explored and structure-activity relationships have been established by several groups. Several compounds within each of these subtypes display sub micromolar potency against DPP IV. The most potent cyanoazetidines and ketoazetidines have large, hydrophobic amino acid groups bound to the azetidine nitrogen and display activities below 100nM. DPP IV inhibition is not sensitive to stereochemistry at the 2- position as both 2-(R)- and 2-(S)-cyano and -keto azetidines display similar inhibitory potencies. While these “warhead”- based cyano- and ketoazetidines have the potential for covalent, bond-forming inhibition, they can also react to internally cyclize into inactive ketopiperazines and dihydroketopyrazine. Thus, chemical instability was also explored for compounds in these two subtypes and certain members of the cyanoazetidine series display aqueous stability comparable to the closely related cyanopyrrolidines. Select 3-fluoroazetidines also display inhibitory potencies below 1μM without the propensity for cyclization and chemical instability associated with the other subseries.
Export Options
About this article
Cite this article as:
Ferraris Dana, Belyakov Sergei, Li Weixing, Oliver Eddie, Ko Yao-Sen, Calvin David, Lautar Susan, Thomas Bert and Rojas Camilo, Azetidine-Based Inhibitors of Dipeptidyl Peptidase IV (DPP IV), Current Topics in Medicinal Chemistry 2007; 7 (6) . https://dx.doi.org/10.2174/156802607780090993
DOI https://dx.doi.org/10.2174/156802607780090993 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Medicinal Chemistry Advancement in Life-Threatening Diseases
The current issue will highlight concise reports that specify ground-breaking insights, including the novel discovery of drug targets and their action mechanism or drugs of novel classes. These are projected to encourage medicinal chemistry future efforts to address the most challenging medical needs. The current issue highlights further efforts to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting the Brain: Advances in Drug Delivery
Current Pharmaceutical Biotechnology Editorial [Hot Topic: Expanding Knowledge on Protein Misfolding: Unravelling the Molecular Basis of Neurodegeneration (Guest Editor: Rosana Chehin)]
Current Protein & Peptide Science Stress, Corticosteroid Hormones and Hippocampal Synaptic Function
CNS & Neurological Disorders - Drug Targets Meet Our Managing Editor:
Neuroscience and Biomedical Engineering (Discontinued) Serum Interleukin-33 is a Predictor of Depression in Patients with Acute Ischemic Stroke
Current Neurovascular Research Individual Triptan Selection in Migraine Attack Therapy
Recent Patents on CNS Drug Discovery (Discontinued) The Therapeutic Impact of New Migraine Discoveries
Current Medicinal Chemistry Editorial: Steroid-Dependent Management of Biological Responses in the Nervous System
CNS & Neurological Disorders - Drug Targets Recent Research on Flavonoids and their Biomedical Applications
Current Medicinal Chemistry The Role of Nuclear Medicine in Vascular Dementia
Vascular Disease Prevention (Discontinued) Treatment Integrity: An Unresolved Issue in Psychotherapy Research
Current Psychiatry Reviews Editorial (Thematic Issue: Genetics: A Window into the Biology of the Mind)
Current Psychiatry Reviews Stress-driven Discovery of Natural Products from Extreme Marine Environment- Kueishantao Hydrothermal Vent, a Case Study of Metal Switch Valve
Current Organic Chemistry Pathogenesis of Stroke-Like Episodes in MELAS: Analysis of Neurovascular Cellular Mechanisms
Current Neurovascular Research Different Levels of Activity in the Left Intraparietal Sulcus Triggered by Lasting and Unlasting Cues in the Posner Task
Neuroscience and Biomedical Engineering (Discontinued) Molecular Self-Assembly of Peptide Nanostructures: Mechanism of Association and Potential Uses
Current Nanoscience Epigenetic Regulation in Particulate Matter-Mediated Cardiopulmonary Toxicities: A Systems Biology Perspective
Current Pharmacogenomics and Personalized Medicine Commentary
CNS & Neurological Disorders - Drug Targets Effective Classification of Major Depressive Disorder Patients Using Machine Learning Techniques
Recent Patents on Computer Science Mass Spectrometry in Drug Discovery: A Current Review
Current Drug Discovery Technologies